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Conditions of increased oxidative stress including cerebral ischemia can lead to blood–
brain barrier dysfunction via matrix metalloproteinase (MMP). It is known that MMP-9 in
particular is released from brain endothelial cells is involved in the neuronal cell death
that occurs after cerebral ischemia. In the intracellular signaling network, apoptosis
signal-regulating kinase 1 (ASK1) is the main activator of the oxidative stress that is
part of the pathogenesis of cerebral ischemia. ASK1 also promotes apoptotic cell death
and brain infarction after ischemia and is associated with vascular permeability and
the formation of brain edema. However, the relationship between ASK1 and MMP-9
after cerebral ischemia remains unknown. Therefore, the aim of the present study
was to determine whether blocking ASK1 would affect MMP-9 activity in the ischemic
brain and cultured brain endothelial cells. Our results showed that ASK1 inhibition
efficiently reduced MMP-9 activity in vivo and in vitro. In endothelial cell cultures, ASK1
inhibition upregulated phosphatidylinositol 3-kinase/Akt/nuclear factor erythroid 2 [NF-
E2]-related factor 2/heme oxygenase-1 signals and downregulated cyclooxygenase-2
signals after hypoxia/reperfusion. Additionally, in neuronal cell cultures, cell death
occurred when neurons were incubated with endothelial cell-conditioned medium (EC-
CM) obtained from the hypoxia/reperfusion group. However, after incubation with
EC-CM and following treatment with the ASK1 inhibitor NQDI-1, neuronal cell death was
efficiently decreased. We conclude that suppressing ASK1 decreases MMP-9 activity in
brain endothelial cells, and leads to decreased neuronal cell death after ischemic injury.
Keywords: apoptosis signal-regulating kinase 1, matrix metalloproteinase, transient focal cerebral ischemia,
hypoxia, brain endothelial cells
Abbreviations: ASK1, apoptosis signal-regulating kinase 1; BBB, blood–brain barrier; CNS, central nervous system; Cox-
2, cyclooxygenase-2; EC-CM, endothelial cell-conditioned medium; HO-1, heme oxygenase-1; H/R, hypoxia/reperfusion;
MMP, matrix metalloproteinase; Nrf-2, nuclear factor erythroid 2 [NF-E2]-related factor 2; OGD, oxygen–glucose
deprivation; PI3K, phosphatidylinositol 3-kinase; ROS, reactive oxygen species.
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INTRODUCTION
After cerebral ischemia, an imbalance of oxidants can lead
to the overproduction and accumulation of ROS. Oxidative
stress is a critical component in the pathogenesis of ischemic
brain injury and the disruption of BBB, which subsequently
causes brain edema and neuronal death (Rosenberg, 1995; Allen
and Bayraktutan, 2009). MMPs are one of the main factors
regulating BBB integrity and neuronal cell death (Rosenberg,
1995; Rosenberg et al., 1996; Romanic et al., 1998). Especially,
it is known that enhanced MMP-9 expression is associated with
neuronal cell damage (Lee and Lo, 2004), apoptosis (Copin et al.,
2005), and vascular disintegration. In contrast, the inhibition of
MMP-9 ameliorates brain edema and infarct volume following
cerebral ischemia (Rosenberg, 1995; Gasche et al., 1999; Asahi
et al., 2001; Wang and Tsirka, 2005; Kelly et al., 2008; Yu et al.,
2008; Hu et al., 2009).
Apoptosis signal-regulating kinase 1 is one of the major
molecules activated in the intracellular system immediately
following ischemic insults (Matsuzawa and Ichijo, 2008; Cheon
et al., 2013). ASK1 is activated by oxidative stress in the
pathogenesis of CNS injuries and disease such as ischemic stroke,
Huntington’s disease, and Alzheimer’s disease (Minn et al., 2008;
Cho et al., 2013; Kawarazaki et al., 2014). A previous study
demonstrated that the induction of ASK1 expression promotes
apoptotic cell death after ischemia, while the silencing ASK1 by
small interfering RNA (siRNA) ameliorates cerebral infarction in
the brain (Kim et al., 2011). The inhibition of ASK1 also exerts
protective effects against ischemia induced brain edema (Song
et al., 2015). ASK1 modulates vascular endothelial growth factor
and aquaporin-1, which is associated with water homeostasis
(Song et al., 2015). Moreover, in microarray analyses, ASK1
silencing reduced the expression of brain endothelial cell-related
genes such as Cdh1, Icam1, Gjb3 and Sele, which are the genes
for cadherin1, intercellular adhesion molecule 1, gap junction
protein beta1, and endothelial cell selectin respectively (Song
et al., 2015). Although, many studies have shown that ASK1 is
linked to vascular injury and neuronal cell death after cerebral
ischemia, it remains unclear whether ASK1 affects MMP-9
activation, which plays a crucial role in ischemic stroke.
Therefore, we conducted the present study to determine
whether the inhibition of ASK1 would attenuate MMP-9
activation in ischemic tissue after middle cerebral artery (MCA)
occlusion and in brain endothelial cells after hypoxia/reperfusion
(H/R) injury. In addition, we investigated whether the inhibition
of ASK1 in endothelial cells under H/R condition would affect
the neuronal cell fate by modulating apoptosis-related markers
and cell viability.
MATERIALS AND METHODS
Animals
All animals were housed in the controlled animal facilities with a
12 h light/dark cycle at Yonsei University. Mice were housed with
1–5 mice in the cage with free access to food and water. Animal
experiment was followed in the Guide to the Care and Use of
Laboratory Animals approved by the Association for Assessment
and Accreditation of Laboratory Animal Care and the National
Institutes of Health guideline. Ethical Committee of the Yonsei
University approved this study. Adult male C57BL/6 mice
(Orient, Seongnam, GyeongGi-Do, Korea; aged 8–12 weeks)
were used in this experiment. The group was divided into three
groups; normal control group (control), ischemia/reperfusion
(I/R) group, and I/R+si-ASK1 group.
Transient Focal Cerebral
Ischemia/Reperfusion
Isoflurane vaporizer was used for anesthesia of mice with
2.0% isoflurane in 30% oxygen and 70% nitrous oxide. Mice
were placed on homeothermic blanket and maintained rectal
temperature at 37 ± 0.5◦C. The MCA was blocked by inserting
6-0 nylon suture into the left external carotid artery (ECA) to
induce transient focal cerebral ischemia (tFCI) for 60 min. The
blood flow was restored by removing the nylon suture. Mice
were housed the cages and monitored during experiments. At
24 h after reperfusion, mice were anesthetized by intraperitoneal
injection of Zoletil mixture (30 mg/kg; VirvacLaboratories,
Carros, France), and performed cardiac perfusion with normal
saline.
The bEnd.3 Cell culture
Mouse brain endothelial cells (bEnd.3, ATCC, Manassas, VA,
USA) were cultured with Dulbecco’s Modified Eagle’s Medium
high glucose (DMEM, HycloneTM, GE Healthcare Life Sciences,
Logan, UT, USA) adding fetal bovine serum (10%; FBS, GE
Healthcare Life Sciences) and penicillin-streptomycin solution
(1%; Thermo Scientific, Waltham, MA, USA). The endothelial
cells were incubated in the CO2 chamber.
The Neuro-2A Cell culture
Murine neuronal cell line, Neuro-2A, was cultured in DMEM
high glucose cultured media, supplemented with 10% FBS
(GE Healthcare Life Sciences) and 1% penicillin-streptomycin
solution (Thermo Scientific). The neuronal cells were incubated
at 37◦C in a humid atmosphere in the presence of 5% CO2. To
examine effects of endothelial cell-released factor on neuronal
cells, neuronal cells were incubated with EC-CM which were
collected after H/R injury.
Hypoxia/Reperfusion Injury
Before OGD, the culture medium was discarded, washed
with phosphate buffer saline (PBS) and changed with
deoxygenated glucose-free balanced salt solution (BSS) under
the anaerobic chamber (Forma Scientific, Inc., Marietta, GA,
USA). Endothelial cells were exposed to OGD condition for
6 h. After hypoxia, BSS solution was discarded and changed
into DMEM cultured media and cells were transferred to a
CO2 incubator for 24 h. After reperfusion, cells and EC-CM
were collected and stored at −80◦C. NQDI-1 (600 nM, Tocris
Bioscience, Bristol, UK), an inhibitor of ASK1, was treated
in cultured media from 1 h before hypoxia to 6 h during
hypoxia.
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siRNA Targeting ASK1
ASK1 gene was silenced by using siRNA (Ambion, Austin,
TX, USA, sense, GCUCGUAAUUUAUACACUGtt; antisense,
CAGUGUAUAAAUUACGAGCtt; 5 µM). A 100 µl solution
of siPORTNeoFX (Ambion) and siRNA for ASK1 was injected
into the lateral ventricle of mice (mediolateral 1.0 mm;
anteroposterior 0.2 mm; dorsoventral 3.1 mm) with an osmotic
pump (Alzet, Cupertino, CA, USA) for 3 days before ischemic
injury.
Cresyl Violet Staining
At 24 h after reperfusion, brain of mice was isolated
after perfusion with saline. Each brain was fixed with 3.7%
formaldehyde and stored at −80◦C. Samples were sectioned
coronally by a cryotome. Thickness of sections was 20 µm.
Sections were stained with cresyl violet (Sigma-Aldrich, St. Louis,
MO, USA) for 3 min and washed with distilled water for
three times. Samples were mounted by using mounting medium
(Vector Laboratories, Inc., Burlingame, CA, USA) and observed
under microscope (Olympus, Tokyo, Japan).
Double Staining for NeuN and TUNEL
Frozen brain sections were sliced by a microtome with 20 µm
thickness. Sections were onto coating slide glass (MUTO
Pure Chemicals Co., Ltd, Tokyo, Japan) and dried at room
temperature. Frozen mouse brain coronal sections were washed
with PBS for one times, and dipped into −20◦C ethyl alcohol
for 20 min, followed by 0.3% Triton X-100 diluted in PBS for
1 h. After washing with PBS, samples were blocked in 5% bovine
serum albumin (BSA) diluted in PBS for 1 h and incubated
with rabbit anti-NeuN antibody (Abcam, Cambridge, UK) at 4◦C
overnight. After washing with PBS, terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay for
measurement for DNA fragmentation was performed followed by
manufacture’s instruction (RocheDiagnostics, Indianapolis, IN,
USA). Hoechst 33342 (ThermoFisher Scientific) or Propidium
iodide (PI; Sigma-Aldrich) was used for counterstaining. After
washing with PBS, stained brain were mounted with Vectashield
(Vector Laboratories, Inc.). After then, sections were observed by
using an LSM 700 confocal laser scanning microscope (Carl Zeiss,
Thornwood, NY, USA).
Western Blot Analysis
The tissues were lysate with a RIPA buffer (Biosesang, Inc.,
Seongnam, South Korea) with HaltTM protease & Phosphatase
inhibitor cocktail (1:100, Thermo Scientific). After centrifuged at
13000 rpm at 4◦C for 20 min, the pellet was collected and protein
concentration was measured by using Pierce R© BCA protein assay
kit (Thermo Scientific). Sample buffer was added and boiled
at 95◦C for 5 min. Samples were transferred to polyvinylidene
difluoride membranes (PVDF, Merck Millipore, Bedford, MA,
USA). Membranes were blocked with 5% BSA and incubated
in the rabbit anti-phosphatidylinositol 3-kinase (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), rabbit anti-pAkt (1:1000,
Cell signaling, Danvers, MA, USA), rabbit anti-Akt (1:1000, Cell
signaling), rabbit anti-nuclear factor erythroid 2 [NF-E2]-related
factor 2 (1:1000, Santa Cruz Biotechnology), rabbit anti- HO-
1 (1:1000, Abcam, Cambridge, UK), rabbit anti-Bcl-2 (1:1000,
Abcam), mouse anti-Bax (1:1000, Merck Millipore), goat anti-
cyclooxygenase-2 (1:500, Santa Cruz Biotechnology), rabbit anti-
cleaved caspase-3 (1:1000, Santa Cruz Biotechnology), and rabbit
anti-caspase-3 (1:1000, Merck Millipore) which is diluted in 2%
BSA. Horseradish peroxidase-conjugated anti-rabbit, anti-goat,
or anti-mouse IgG reagents (1:5000) were used as secondary
antibodies (Jackson ImmunoRearch Laboratories, West Grove,
PA, USA). The β-actin (1:5000, Santa Cruz Biotechnology) was
used as an internal control. The bands were visualized with
enhanced chemiluminescence reagents (West-Q pico Dura ECL
solutions; GenDEPOT, Barker, TX, USA) under the LAS 4000
program (GE Healthcare, Pittsburgh, PA, USA).
Immunocytochemistry
The endothelial cells onto the coated slide were fixed with 4%
paraformaldehyde (PFA) for overnight at 4◦C. After washing with
PBS for three times, cells were blocked with 5% BSA for 1 h at
room temperature. After washing with PBS, cells were reacted
by the rabbit anti-PI3K (Santa Cruz Biotechnology), rabbit anti-
pAkt (1:1000, Cell signaling), rabbit anti-Nrf-2 (1:1000, Santa
Cruz Biotechnology), rabbit anti-HO-1 (1:1000, Abcam) and
goat anti-Cox-2 (1:500, Santa Cruz Biotechnology) respectively
at 4◦C for 1 day, followed by FITC or Rhodamine-conjugated
secondary antibody (1:1000, Jackson ImmunoResearch) at room
temperature for 2 h. After washing with PBS, stained cells were
mounted with Vectashield with DAPI (Vector Lab). Slides were
observed under LSM 710 confocal laser scanning microscope
(Carl Zeiss).
Cell Viability
WST assay (EZ-CYTOX, Daeillab Service, Seoul, South Korea)
was used for detecting cell viability of Neuro-2A cells. One day
before performing the assay, the Neuro-2A cells were seeded in
96-well plates at a density 1 × 104 cells per well with 100 µl of
DMEM culture medium. After incubation with EC-CM for 24 h,
WST (10 µl) in cultured media (100 µl) was added in each well.
After 1 h 30 min reaction time at 37◦C, the resultants were red
by using VERSASA max microplate reader (Molecular Devices,
Sunnyvale, CA, USA) at a wavelength 450 nm.
MMP-9 Activity Assay
For the assessment of activity of MMP-9 in tissue, endothelial
cell, and endothelia cell media, MMP-9 Biotrak Activity Assay
system (Amersham Biosciences, Piscataway, NJ, USA) was used
according to the manufacturer’s instructions. Tissue lysate, cell
lysate, or cultured cell media was added into MMP-9 coated
wells and incubated overnight for immunoreactivity at 4◦C.
To measure active MMP-9, detection enzyme was added and
incubated at 37◦C. The resultants were read by ELISA reader at
450 nm.
Hoechst/PI Staining Assay
For detection of apoptosis in neuronal cells, Hoechst 33342/PI
double staining was performed. Neuronal cells were incubated
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with Hoechst 33342 (10 µg/mL; ThermoFisher scientific) was or
PI (Sigma-Aldrich) at 37◦C for 10 min in the dark. After staining,
cells were placed on a microscope slides and observed by LSM710
confocal microscope (Carl Zeiss). Hoechst 33342 is used for live
cell staining of DNA and nuclei and PI is used for dead cell
staining.
Flow Cytometry
Neuro-2A cells were seeded in 100 mm dishes at a density 4× 106
cells and incubated with EC-CM for 24 h. Cells were washed
with DPBS and collected. And then, cell suspensions were filtered
through a cell strainer with a 40 µm nylon mesh. PI solution
(10 µl) was added and incubated at room temperature for 10 min
in the dark. Fluorescent cells (PI-positive) were determined
immediately by using flow cytometer (LSR II, BD bioscience, San
Hose, CA, USA). Flow cytometry data was analyzed using FlowJo
version 10.
Statistical Analysis
Data are expressed as the mean ± standard error of the mean
(SEM). Statistical comparisons among the groups were assessed
with a one way ANOVA followed by a Tukey post hoc test (Prism
version 6.0 software). Statistical significance between groups was
considered to be present at ∗p< 0.05, ∗∗p< 0.01, ∗∗∗p< 0.001.
RESULTS
Ischemic Injury Promotes Neuronal Cell
Death at 24 h after Ischemia/Reperfusion
We performed cresyl violet staining to assess the morphological
alterations that occur in cells after ischemic injury (Figure 1A).
In the control group, round and healthy cells were noted in the
cerebral cortex and striatum, whereas in the I/R group, small
and thin cell bodies were observed in the damaged cortex and
striatum 24 h after ischemic injury. To examine whether ischemia
induces neuronal cell death, we performed immunolabeling and
TUNEL assays (Figure 1B). Compared to the control group,
fewer neuronal nuclei NeuN-positive cells in the I/R group,
were co-localized with TUNEL-positive cells in the striatum.
Moreover, in the cortex, many TUNEL-positive cells were merged
with NeuN-positive cells in the I/R group. However, TUNEL-
positive cells (red) were not detected in the cortex and striatum of
the control group. These results indicate that I/R injury promoted
neuronal cell death in the lesioned brain areas at 24 h after I/R.
Activated MMP-9 was Reversed by
Blocking ASK1 Expression after
Transient Focal Cerebral Ischemia
The previous study demonstrated that synthetic siRNA for ASK1
efficiently suppresses ASK1 and subsequently pASK1 after I/R
(Kim et al., 2011). We used this method. To suppress the ASK1
level, siRNA (sense, GCUCGUAAUUUAUACACUGtt; antisense,
CAGUGUAUAAAUUACGAGCtt) was injected through the
intracerebroventricular route (Supplementary Figure S1). To
confirm that ASK1 could be silenced efficiently by siRNA, we
FIGURE 1 | Increased neuronal cell death in the brain after I/R.
(A) Morphological alterations were assessed by cresyl violet staining at 24 h
after transient focal cerebral ischemia (tFCI). Round cell bodies were observed
in the striatum and cortex of the control group, whereas thin and small cell
bodies were noted in the striatum and cortex of the I/R group at 24 h after
tFCI. (B) DNA fragmentation was labeled by TUNEL assays at 24 h after tFCI.
NeuN-positive cells (green) and TUNEL-positive cells (red) were co-expressed
in the striatum and cortex of the I/R group; however, TUNEL-positive cells
were not easily found in these brain areas in the control group. Hoechst
33342 was used for counterstaining. TUNEL, terminal deoxynucleotidyl
transferase dUTP nick end labeling.
performed immunohistochemistry after tFCI. Our results showed
that the increased ASK1 expression after ischemia was well-
silenced by siRNA (Figure 2A). Next, to determine whether I/R
and ASK1 could modulate MMP-9, we performed an MMP-9
activity assay at 24 h after I/R (Figure 2B). Our results showed
that the level of active MMP-9 was significantly increased in
the I/R group compared to the level in the control group.
After silencing ASK1 with siRNA, the levels of active MMP-9
were efficiently attenuated in the brain tissue despite the I/R
injury. Thus, ASK1 may contribute to MMP-9 activation at 24 h
after I/R.
MMP-9 Activity in Endothelial
Cell-Conditioned Medium was
Downregulated after the Inhibition of
ASK1
The MMP-9 that is secreted from endothelial cells plays pivotal
roles in BBB disruption, endothelial cell morphogenesis, and
capillary formation (Dong et al., 2009; Dao Thi et al., 2012).
Thus, we performed MMP-9 activity assay in cell media and
cultured endothelial cells after 6 h (hypoxia)/24 h (reperfusion;
Figures 3A,B). Our results showed that in EC-CM, the level of
MMP-9 in the H/R group, was obviously increased compared
to that in the control group. In the group treated with the
ASK1 inhibitor NQDI-1, MMP-9 activity level was lower than
that in the EC-CM of the H/R group (Figure 3A). However,
in endothelial cells, the levels of active MMP-9 were not
significantly different among the groups (Figure 3B).
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FIGURE 2 | Alteration in MMP-9 activity after ASK1 inhibition in the brain after I/R. (A) Immnohistochemistry images show dense ASK1 expression in the
striatum and cortex of mouse brain from the I/R group. After being treated with si-ASK1, the ASK1 level was efficiently diminished in the brains of the I/R+si-ASK
group compared to the level in the I/R group. (B) MMP-9 activity was measured with an MMP-9 activity assay kit at 24 h after I/R in vivo. The elevated MMP-9 activity
that was observed in the I/R group compared to that in the control group was alleviated by silencing ASK1 through genetic manipulations at 24 h after I/R (n = 6).
[ASK1-siRNA sense, GCUCGUAAUUUAUACACUGtt; antisense, CAGUGUAUAAAUUACGAGCt; Bars represent mean ± SEM, n = 6. Active MMP-9 (ng/mL):
control, 0.083 ± 0.004; I/R, 0.117 ± 0.008; I/R+si-ASK1, 0.101 ± 0.003. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001]. PI, propidium iodide, I/R, ischemia/reperfusion.
FIGURE 3 | Alterations of MMP-9 activity after inhibiting ASK1 in the EC-CM following H/R. (A) In the EC-CM, MMP-9 activity was measured with an
activity assay kit after H/R. After H/R, MMP-9 activity increased, but treatment with NQDI-1, an inhibitor of ASK1, restored the level of MMP-9 activity to that of the
control group (n = 7). (B) In the cultured endothelial cells, no significant differences in MMP-9 activity were noted among the three groups (n = 3). [Bars represent
mean ± SEM, Active MMP-9 (ng/mL) in EC-CM (n = 7): control, 0.135 ± 0.010; H/R, 0.435 ± 0.046; H/R+NQDI-1, 0.171 ± 0.199. Active MMP-9 (ng/mL)
in endothelial cells (n = 3): control, 0.258 ± 0.014; H/R, 0.266 ± 0.012; H/R+NQDI-1, 0.261 ± 0.004. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001]. H/R,
hypoxia/reperfusion.
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ASK1 Suppression Increased
PI3K/Akt/Nrf-2/HO-1 Signaling Pathway
and Decreased Cox-2 Signaling in
Endothelial Cells
To elucidate the mechanisms underlying the protective
effects of ASK1 inhibition against MMP-9 in endothelial cells
during H/R, we performed Western blot analysis (Figure 4)
and immunocytochemistry (Figure 5). A previous study
demonstrated that exposure to oxidative stress induces PI3K/Akt
signaling, which activates pro-survival reactions after stimuli
(Wang et al., 2007). Based on this previous study, we assessed
the PI3K protein levels after oxidative stress in endothelial
cells. However, the PI3K protein level of these cells was not
altered after exposure to H/R. Interestingly, the PI3K level in
NQDI-1-treated cells was significantly increased at 24 h after
H/R (Figures 4A,B). Using Western blots, we also measured the
level of Akt protein, which is downstream of PI3K. Although the
quantitative graph showed that the level of phosphorylated-Akt
(pAkt) in the H/R group was upregulated, compared to the level
in the control group, after treatment with NQDI-1, the pAkt
level increased further despite the H/R injury (Figures 4A,C).
Next, we hypothesized that PI3K/Akt as upstream signaling
molecules signals would modulate the Nrf-2/HO-1 pathway
during hypoxia injury (Martin et al., 2004; Wu et al., 2013;
Meng et al., 2014; Xu X.H. et al., 2015). The results of our
Western blot analysis revealed that the, Nrf-2 protein level
was also significantly upregulated, compared to the level in the
H/R group after blocking ASK1 with NQDI-1 (Figures 4A,D).
The HO-1 protein levels in the H/R group were not increased
compared to the levels in the control group; however, blocking
ASK1 increased the HO-1 levels regardless of the H/R injury
(Figures 4A,E). It has been recognized that Cox-2 is an important
mediator of ischemic injury development in the brain (Nogawa
et al., 1997). Our data indicated that following H/R injury, the
Cox-2 protein levels were reduced after treatment with NQDI-1
(Figures 4A,F). Next, we performed immunocytochemistry.
Our data demonstrated that PI3K-positive cells (red) showed
markedly decreased immunoreactivity in the H/R group. On
the other hand, PI3K expression in the H/R+NQDI-1 group
was enhanced, compared to the expression in the control
and H/R groups (Figure 5A). Additionally, pAkt (red) was
highly expressed in a cytosol-like pattern in the H/R+NQDI-1
group, compared to in the H/R group (Figure 5B). We also
observed lower Nrf-2 immunoreactivity in the H/R group.
After blocking the ASK1 signal, the expression of Nrf-2 in
the H/R+NQDI-1 group was increased compared to that
in the H/R group (Figure 5C). No HO-1 expression was
observed in the H/R group, but intense HO-1 expression was
noted in the H/R+NQDI-1 group (Figure 5D). In contrast,
Cox-2 expression was upregulated in H/R-injured endothelial
cells, but was downregulated after ASK1 inhibition despite
the H/R injury (Figure 5E). Collectively, our data suggest
that ASK1 inhibition reduces Cox-2 signals but increases
PI3K/Akt/Nrf-2/HO-1 signaling after H/R injury in endothelial
cells.
FIGURE 4 | Upregulated PI3K/Akt/Nrf-2/HO-1 signals and downregulated Cox-2 signals in endothelial cells after ASK1 inhibition and H/R. (A) The
amounts of PI3K, Akt, Nrf-2, HO-1, and Cox-2, as measured by Western blotting in the three groups. (B) Results of the semi-quantitative analysis showed that the
PI3K level was higher in the H/R+NQDI-1 group than it was in the other groups (n = 3). (C) The protein level of pAkt was upregulated after H/R, but treatment with
NQDI-1 significantly increased the pAkt level (n = 3). (D,E) Quantification of Nrf-2 and HO-1 revealed that the inhibition of ASK1 by NQDI-1 significantly increased the
levels of these factors (n = 3). (F) The Cox-2 protein level in the H/R+NQDI-1 group was lower than that in the H/R group (n = 3−4). β-actin was used as an internal
control. [Bars represent mean ± SEM, n = 3–4. Relative optical density (OD) of PI3K: H/R, 0. 90 ± 0.04; H/R+NQDI-1, 2.08 ± 0.04. OD of pAkt: H/R, 1.53 ± 0.09;
H/R+NQDI-1, 1.74 ± 0.09. OD of Nrf-2: H/R, 1.14 ± 0.05; H/R+NQDI-1, 2.07 ± 0.16. OD of HO-1: H/R, 1.05 ± 0.03; H/R+NQDI-1, 2.08 ± 0.06. OD of Cox-2:
H/R, 1.08 ± 0.05; H/R+NQDI-1, 0.70 ± 0.13. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001]. H/R, hypoxia/reperfusion.
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FIGURE 5 | Elevated PI3K/Akt/Nrf-2/HO-1 expressions and reduced Cox-2 expression in endothelial cells after ASK1 inhibition and H/R. The levels of
PI3K/Akt/Nrf-2/HO-1 and Cox-2 expression were evaluated by immunocytochemistry after H/R. (A) Representative image showing that following H/R, PI3K
expression (red) was markedly observed after inhibiting ASK1 with NQDI-1 compared to the expression levels in the control and H/R groups. (B–D) Confocal image
demonstrating that ASK1 inhibition increased Akt, Nrf-2, and HO-1 expression, respectively. (E) Blocking ASK1 reduced Cox-2 expression (green) in endothelial cells
after H/R. DAPI was used as a counterstain. H/R, hypoxia/reperfusion.
Apoptotic Molecules Were Attenuated
after Incubation with ASK1
Inhibitor-Treated EC-CM
To elucidate whether ASK1 and MMP-9 modulate neuronal
cell fate, we treated neuronal cells with EC-CM and performed
Western blot analyses and cell viability assays. We measured the
protein levels of B-cell lymphoma 2 (Bcl-2) an anti-apoptotic
marker, and Bcl-2-associated X (Bax), a pro-apoptotic marker,
and caspase-3, an apoptotic molecule, in the neuronal cell
culture (Figure 6). The quantitative analysis demonstrated that
the Bcl-2 level was decreased in neuronal cells incubated with
H/R-injured EC-CM. However, neuronal cells incubated with
H/R+NQDI-1-treated EC-CM showed efficiently increased Bcl-2
levels (Figure 6B). In contrast to the results for Bcl-2, the
Bax expression level was obviously increased in neuronal cells
exposed to H/R-injured EC-CM. After attenuating of ASK1
in the EC-CM, the Bax protein level was downregulated in
neuronal cells (Figure 6C). Cleaved caspase-3 level in neuronal
cells was elevated in neuronal cells incubated with H/R-
injured EC-CM, this level was reversed after H/R+NQDI-
1-treated EC-CM (Figure 6E). To investigate the neuronal
cell viability, viability assays were conducted at 24 h after
EC-CM incubation (Figure 6F). After normalizing the cell
viability with the control values, the cell viability (%) of
neuronal cells incubated with the H/R group was 71.32%;
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FIGURE 6 | Reduction of apoptotic molecules following the inhibition of ASK1. (A) The levels of anti-apoptotic (Bcl-2) and pro-apoptotic (Bax) proteins were
detected with Western blot analyses. (B) The relative optical density indicated that neuronal Bcl-2 expression was reduced after incubating the cells with EC-CM
from the H/R group. After incubation with NQDI-1-treated EC-CM, the Bcl-2 level was increased (n = 3). (C) The increased Bax level that was observed after
incubating the cells with H/R-injured EC-CM was reduced after NQDI-1 treatment (n = 3−4). (D) The level of apoptotic (caspase-3) protein was measured by
Western blot analyses. (E) The graph showed the cleaved caspase-3 was increased in H/R-injured EC-CM, whereas ASK1-inhibited group exhibited lower cleaved
caspase-3 level in neuronal cells (n = 3). (F) Cell viability was detected with viability assays. The quantitative analyses show that neuronal cells were significantly dead
after incubation with H/R-injured EC-CM; however, the cell viability was increased by treatment with ASK1 inhibitor (n = 7). β-actin was used as an internal control.
[Bars represent mean ± SEM, n = 3–4. Relative optical density (OD) of Bcl-2: H/R, 0. 79 ± 0.04; H/R+NQDI-1, 1.10 ± 0.05. OD of Bax: H/R, 1.27 ± 0.08;
H/R+NQDI-1, 1.01 ± 0.04. OD of cleaved caspase-3: H/R, 1.17 ± 0.04; H/R+NQDI-1, 0.92 ± 0.05. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001]. H/R,
hypoxia/reperfusion; EC-CM, endothelial cell-conditioned medium.
however, the cell viability increased to 83.42% after incubation
with ASK1 inhibitor-treated EC-CM. These results indicated
that apoptotic factors were downregulated and anti-apoptotic
factor was upregulated in neuronal cells after inhibition of
ASK1.
Neuronal Cell Death was Decreased
after Incubation with ASK1
Inhibitor-Treated EC-CM
To confirm that the apoptosis-related molecules regulated by
ASK1 lead to neuronal cell death, we performed Hoechst/PI
dual staining and FACS analysis (Figure 7). Confocal images
showed that PI-positive cells (red) were found easily in neuronal
cells which incubated with EC-CM after H/R, however, neuronal
cells with ASK1 inhibited EC-CM showed lower PI-positive
cells and in the control group, we cannot observe PI-positive
cells (Figure 7A). Single cell suspensions were labeled with
PI and analyzed by flow cytometry after incubation with
EC-CM. A primary gating was based on forward and side light
scatter respectively and cell debris were excluded (Figure 7B).
Sorted cells were measured by PI fluorescence laser. The dot
plot showed that neuronal cells in the H/R group showed
a much higher amount of PI-positive cells (cell percentage;
32.7%) compared to those in the H/R+NQDI-1 group (cell
percentage; 23.9%; Figure 7C). In addition, merged histogram
exhibited increased PI-positive cell counts in the H/R group,
compared to those in the H/R+NQDI-1 group (Figure 7D).
In the ischemic brain tissue, after silencing ASK1, a marked
reduction in apoptotic cell death was detected by using a
TUNEL assay in vivo (Supplementary Figure S2). These data
suggest that neuronal cell death was ameliorated by inhibiting
ASK1.
DISCUSSION
In the pathology of cerebral ischemia, oxidative stress is one
of the major causes of brain damage and neuronal cell death.
Many therapeutic approaches for addressing oxidative stress-
induced BBB disruption and neuronal cell death have been
developed. However, no curative strategies currently exist. In
the present study, neuronal cell death occurred in the ipsilateral
hemispheres of mice brains that were exposed to ischemic insults,
and this finding was in accordance with the results of several
previous studies (Kim et al., 2011; Cheon et al., 2013). Within
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FIGURE 7 | Decrease of neuronal cell death following the inhibition of ASK1. (A) Using Hoechst33342/PI staining, dead cell (PI-positive, red) was observed
by confocal microscope. PI-positive cells rarely detected in the H/R+NQDI-1 group compared to that in the H/R group. (B) Representative flow cytogram showed
the gating for PI-positive cell analysis. (C,D) Dot plot and histogram showed that many PI-positive cells was sorted in the H/R group, however, relatively lower
PI-positive cells were detected in the H/R+NQDI-1 group. PI, propidium iodide; H/R, hypoxia/reperfusion.
the ischemic lesion, the level of MMP-9, which is known to be
secreted by brain endothelial cells, was elevated at 24 h after
I/R. Similarly, we detected activated MMP-9 after H/R injury
in endothelial cell media. However, silencing ASK1, an early
responder in the intracellular cascade that is related to oxidative
stress, ameliorated MMP-9 activation in both the ischemic
brain and endothelial cell media. To elucidate the mechanisms
underlying the ASK1-induced MMP-9 activation, we genetically
and chemically inhibited ASK1. Our results in cultured brain
endothelial cells demonstrated that ASK1 inhibition leads to the
upregulation of PI3K/Akt/Nrf-2/HO-1 and the downregulation
of Cox-2 signals in intracellular cascades (Figure 8). We also
found that neuronal cells incubated with H/R treated EC-CM,
in which high levels of active MMP-9 were detected, showed
increased levels of the pro-apoptotic molecule Bax and caspase-
3, significantly lower cell viability, and higher PI-positive cells
than the control group. However, these results were reversed
following the blockade of ASK1 and the subsequent suppression
of active MMP-9. After incubating cultured neuronal cells with
NQDI-1 treated EC-CM, higher expression of the anti-apoptotic
molecule Bcl-2 was noted, the cell viability was higher, and
PI-positive cells were lower than those of the H/R group.
In addition, DNA fragmentation, a characteristic of apoptosis,
was attenuated in various brain regions including the cerebral
cortex and striatum after ischemic stroke. Together, our data
demonstrated that inhibiting ASK1 suppressed the secretion of
active MMP-9 from injured endothelial cells and contributed
to the observed reduction in neuronal cell death after ischemic
insult.
Following cerebral ischemia, neuronal cell death occurs in the
affected areas. MMP-9 expression is the main factor contributing
to the progression of neuronal apoptosis and the subsequent
brain infarct (Romanic et al., 1998; Dong et al., 2009). Our
data show that blocking ASK1 reduces the secretion of MMP-9
from in endothelial cells. These findings indicate that ASK1
may contribute to the signaling pathway that is associated
with MMP-9 activation. The molecular mechanisms underlying
the induction of MMP-9 by ASK1 in endothelial cells are
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FIGURE 8 | Inhibition of ASK1 reduced MMP-9 activity and subsequent neuronal cell death after ischemic or hypoxic injury.
currently unknown, however, previous studies demonstrated
that MMP-9 activation may be associated with Cox-2 signals
(Dong et al., 2009). Indeed, ours study reveal that ASK1
inhibition induced decreases in Cox-2, thus suppressing
MMP-9. Therefore, MMP-9 activation may be inhibited via
the amelioration of the ASK1-Cox-2 pathway. Although
relationship between ASK1 and Cox-2 is little established in
ischemic model, in macrophage cell line, ASK1 is associated
to Cox-2 expression following peptidoglycan stimulation (Hsu
et al., 2010). In addition, several studies reported that Cox-
2 regulates vascular endothelial cell function and external
stimuli, such as lipopolysaccharide, Cox-2 expression increases
in brain microvascular endothelial cells (Williams et al., 1999;
Ejima et al., 2003). Cox-2 is also an important contributor
to the progression of brain injury after cerebral ischemia,
as studies have shown that the pharmacological or genetic
silencing of Cox-2 results in decreased brain damage, while the
overexpression of Cox-2 increases the brain’s vulnerability to
ischemic injury (Nogawa et al., 1997; Dore et al., 2003; Sasaki
et al., 2004; Kunz et al., 2007). Furthermore, a recent study
demonstrated that inhibitors of Cox-2 decrease the expression
of active-MMP-9 in neuronal and endothelial cells and prevent
edema formation in the brain after ischemia (Dong et al.,
2009).
Heme oxygenase-1 is recognized as a promising therapeutic
target in oxidative stress induced pathological conditions
(Aztatzi-Santillan et al., 2010). HO-1 is a cytoprotective phase
II enzyme that exerts anti-apoptotic and anti-oxidant effects
on the vascular system and controls the function of the BBB
via its interactions with proteases (Lin et al., 2007; Chung
et al., 2008). Here, ASK1 inhibition induced HO-1 expression
and suppressed MMP-9 activity in endothelial cell cultures.
A previous study showed that Nrf-2 mediates phase II enzyme
activity as an upstream molecule of HO-1 and increases HO-1
expression under conditions of oxidative stress (Xu X. et al.,
2015). The inhibition of Nrf-2 by brusatol resulted in damaged
Nrf-2-mediated defense activity (Ren et al., 2011; Xu X. et al.,
2015). Several studies demonstrated that the PI3K/Akt signaling
pathway contributes to cellular defense and cell survival, as well
as modulates Nrf-2 as an upstream signal (Martin et al., 2004;
Ren et al., 2011; Xu X. et al., 2015). Blocking the PI3K/Akt
signaling pathway with LY294002 reduces HO-1 expression in
lipopolysaccharide-induced macrophages (Xu X. et al., 2015).
Additionally, in an experimental mimic model of ischemic
stroke, the upregulation of PI3K/Akt meditated Nrf-2 signaling
pathway causes further HO-1 activation and neuroprotective
effects (Martin et al., 2004; Wu et al., 2013; Meng et al., 2014;
Xu X.H. et al., 2015). It is also well-known that Akt is a negative
regulator of ASK1 activity under ischemic conditions (Wang
et al., 2007) and that Akt attenuates ASK1 activity by directly
phosphorylating at Ser-83 (Wang et al., 2007). Therefore, through
the phosphorylation of Ser-83 in an ASK1-dependent manner,
the ASK1/c-Jun N-terminal kinase pathway was attenuated via
PI3K/Akt activation (Wang et al., 2007). In contrast, a previous
study demonstrated that PI3K/Akt signaling was inhibited by
ASK1 (Subramanyam et al., 2010). Although it is not clear
whether Akt or ASK1 is controlled as an upstream molecule,
we found that ASK1 is closely related to Akt mechanistically.
Our results imply that the ASK1 blockade may have enhanced
the defense system by upregulating PI3K/Akt/Nrf-2 and HO-
1 signals and downregulating Cox-2 signals, which is likely
to reduce the secretion of MMP-9. However, our findings
showed only expression changes in endothelial cell, therefore,
it is difficult that MMP-9 suppression was directly induced
by PI3K/Akt/Nrf-2/HO-1 and Cox-2. This investigation is our
further study.
Although, previous study proved that siRNA for ASK1
has an efficient capability for reducing ASK1 level and ASK1
silencing contributes to cell survival (Kim et al., 2011). The
protective action mechanism by blocking ASK1 in neuronal
cells has not been fully elucidated. Important point from
our results is that endothelial ASK1 can modulate neuronal
cell signalings. It is likely that active MMP-9 secretion
from endothelial cells contribute to ASK1 mechanism.
The early phase of MMP-9 inhibition by siRNA blocks
MMP-9 secretion from endothelial cells, leading to a
decreased the infarct volume (Hu et al., 2009). On the
contrary, MMP-9 expression exacerbates ischemic brain
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injury (Romanic et al., 1998). Similar to previous studies, in our
results, the inhibition of MMP-9 activation by ASK1 blocking
showed an effect on neuronal cell fate in response to ischemic
injury. After incubation with endothelial cell media after H/R,
which contained high level of active MMP-9, the levels of the
anti-apoptotic Bcl-2 were reduced while the levels of the pro-
apoptotic Bax and apoptotic caspase-3 were increased in neurons.
Higher amounts of apoptotic molecules could promote neuronal
apoptosis. After ASK1 blocking, Bcl-2 was upregulated and Bax
and caspase-3 was downregulated, and these changes might
be modulated by ASK1 inhibition and MMP-9 suppression.
Subsequent neuronal cell death was reduced. Furthermore, in
ischemic brain, easily observed apoptotic cell death was reversed
by the silence of ASK1.
Collectively, our findings provide that inhibition of ASK1
might be a novel approach that can protect against vascular
damage and neuronal cell death after cerebral ischemia. Since
the brain injury that occurs after cerebral ischemia is a result of
neuronal cell death with contributions both ASK1 and MMP-9
activation. Inhibition of ASK1 could be an efficient strategy for
attenuating MMP-9 activation and preventing neuronal cell death
after ischemic stroke.
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